Prices are dropping faster than Myles Garrett from fantasy football rosters just as costs are about to rise.
CGC reported a wider than expected loss that included a slew of write-downs leading some to conclude this a kitchen sink quarter.
Cannabis consumers have become very cautious as to the products they purchase.
Canaccord cuts price target for the firm that's set to release earnings Nov. 20.
Joint venture partner Emerald Health appears to be struggling.
These 'bearish bets' are showing both technical and quantitative deterioration.
The point here is an exit doesn't have to be permanent. It is part of a risk management strategy, not an absolute end of a trade.
I thought the sector might have been bottoming out, but it's not.
This group appears oversold and downgrades of the big cannabis names may trigger a "buy the bad news" reaction.
Let's see what the charts and indicators have in store.
I'm not disappointed that Village Farms is raising money. I'm disappointed in how it transpired.
Why I'm leaning toward a trade in the former cannabis darling.
The producer of alcoholic beverages offers mixed technical signals, though trading volume in the shares has been diminishing this year.
While women have become an increasingly large presence in cannabis companies, they are still lagging in positions of leadership.
Black-market vaping has made the entire cannabis group toxic.
What is the green swan that will bring buyers back to cannabis companies?
I'm considering establishing a long investment stake in a package of cannabis stocks, with emphasis on U.S.-based companies.
This looks like a good opportunity to take a fresh look at the charts and indicators of the former 'high flyer'.
After a negative report on GW's epilepsy treatment, the analyst refused to explain the results with me, bringing more questions than answers about its conclusions.
Shares of the cannabinoid prescription medicine company look to be in a weak state.
Let's go to the charts and indicators.
Shares of the cannabis company are likely to drift lower in the weeks ahead.
Singer teamed up with company this week, sending its stock on a wild ride.
A cautious approach by the state is having a wicked effect on earnings and estimates.
Several watchers and market players are deep in the weeds, tracking short action and key companies like Canopy Growth, trying to find out whether the industry has turned over a new leaf.
Is this cannabis name a long-term winner or a one-hit wonder?
Let's check out the charts and indicators to see if they are growing fast too.
Cannabis companies -- like any other firm -- rely on software to help handle sales and the keep the books in order, and it turns out just five are dominant players in the scene.
A host of other cannabis-related stocks has sprouted up that appear better for investing.
After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.